{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:02:31Z","timestamp":1769817751690,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004856","name":"New York State Department of Health","doi-asserted-by":"publisher","award":["C030159"],"award-info":[{"award-number":["C030159"]}],"id":[{"id":"10.13039\/100004856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012636","name":"New York State Stem Cell Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jcyt.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T08:34:43Z","timestamp":1621413283000},"page":"841-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of a clinical-grade, cryopreserved, ex vivo-expanded stem cell product from cryopreserved primary umbilical cord blood demonstrates multilineage hematopoietic engraftment in mouse xenografts"],"prefix":"10.1016","volume":"23","author":[{"given":"Christoph","family":"Schaniel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luena","family":"Papa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia L.","family":"Meseck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Kintali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour","family":"Djedaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Zangui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Iancu-Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jcyt.2021.04.001_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2012.06.005","article-title":"Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation","volume":"18","author":"Kanda","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2021.04.001_bib0002","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bbmt.2013.03.009","article-title":"Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis","volume":"19","author":"Bourgeois","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2021.04.001_bib0003","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bmt.1705979","article-title":"Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I\/II clinical trial","volume":"41","author":"de Lima","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2021.04.001_bib0004","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nm.2080","article-title":"Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution","volume":"16","author":"Delaney","year":"2010","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jcyt.2021.04.001_bib0005","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1172\/JCI74556","article-title":"Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment","volume":"124","author":"Horwitz","year":"2014","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jcyt.2021.04.001_bib0006","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.stem.2015.10.004","article-title":"Phase I\/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft","volume":"18","author":"Wagner","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.jcyt.2021.04.001_bib0007","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.bbmt.2017.04.001","article-title":"Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization","volume":"23","author":"Anand","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jcyt.2021.04.001_bib0008","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.bbmt.2018.02.012","article-title":"Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation","volume":"24","author":"Stiff","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2021.04.001_bib0009","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1200\/JCO.18.00053","article-title":"Phase I\/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide","volume":"37","author":"Horwitz","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2021.04.001_bib0010","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/S2352-3026(19)30202-9","article-title":"Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study","volume":"7","author":"Cohen","year":"2020","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.jcyt.2021.04.001_bib0011","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1172\/JCI70313","article-title":"Epigenetic reprogramming induces the expansion of cord blood stem cells","volume":"124","author":"Chaurasia","year":"2014","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jcyt.2021.04.001_bib0012","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/sctm.19-0199","article-title":"Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor","volume":"9","author":"Zimran","year":"2020","journal-title":"Stem Cells Transl Med"},{"issue":"22","key":"10.1016\/j.jcyt.2021.04.001_bib0013","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1182\/blood.V128.22.818.818","article-title":"Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies","volume":"128","author":"Iancu-Rubin","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jcyt.2021.04.001_bib0014","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s12015-020-09981-w","article-title":"Mechanistic Basis of Ex Vivo Umbilical Cord Blood Stem Progenitor Cell Expansion","volume":"16","author":"Sica","year":"2020","journal-title":"Stem Cell Rev Rep"},{"issue":"5997","key":"10.1016\/j.jcyt.2021.04.001_bib0015","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Boitano","year":"2010","journal-title":"Science"},{"issue":"6203","key":"10.1016\/j.jcyt.2021.04.001_bib0016","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1256337","article-title":"Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal","volume":"345","author":"Fares","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jcyt.2021.04.001_bib0017","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbmt.2017.03.006","article-title":"Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies","volume":"23","author":"Barker","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jcyt.2021.04.001_bib0018","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/14653240410004916","article-title":"Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine","volume":"6","author":"Peled","year":"2004","journal-title":"Cytotherapy"},{"issue":"7763","key":"10.1016\/j.jcyt.2021.04.001_bib0019","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-019-1244-x","article-title":"Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation","volume":"571","author":"Wilkinson","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcyt.2021.04.001_bib0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13287-019-1275-0","article-title":"Safety and efficacy of ex vivo expanded CD34(+) stem cells in murine and primate models","volume":"10","author":"Zhang","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"10.1016\/j.jcyt.2021.04.001_bib0021","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/s41591-019-0601-5","article-title":"Expansion of primitive human hematopoietic stem cells by culture in a zwitterionic hydrogel","volume":"25","author":"Bai","year":"2019","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.jcyt.2021.04.001_bib0022","doi-asserted-by":"crossref","first-page":"2410-2415","DOI":"10.1182\/blood.2020005357","article-title":"The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes","volume":"136","author":"Hua","year":"2020","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jcyt.2021.04.001_bib0023","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/trf.12015","article-title":"Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells","volume":"53","author":"Duchez","year":"2013","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.jcyt.2021.04.001_bib0024","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jcyt.2016.08.004","article-title":"Clinical-scale validation of a new efficient procedure for cryopreservation of ex vivo expanded cord blood hematopoietic stem and progenitor cells","volume":"18","author":"Duchez","year":"2016","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.jcyt.2021.04.001_bib0025","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.5966\/sctm.2014-0284","article-title":"Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells","volume":"4","author":"Heinz","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2021.04.001_bib0026","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13287-017-0625-z","article-title":"A small-molecule\/cytokine combination enhances hematopoietic stem cell proliferation via inhibition of cell differentiation","volume":"8","author":"Wang","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"414","key":"10.1016\/j.jcyt.2021.04.001_bib0027","doi-asserted-by":"crossref","first-page":"eaan1145","DOI":"10.1126\/scitranslmed.aan1145","article-title":"A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates","volume":"9","author":"Radtke","year":"2017","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.jcyt.2021.04.001_bib0028","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/sctm.17-0251","article-title":"Ex Vivo Expansion of CD34(+) CD90(+) CD49f(+) Hematopoietic Stem and Progenitor Cells from Non-Enriched Umbilical Cord Blood with Azole Compounds","volume":"7","author":"Bari","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"10.1016\/j.jcyt.2021.04.001_bib0029","first-page":"517","article-title":"Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation","volume":"84","author":"Meldgaard Knudsen","year":"1999","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jcyt.2021.04.001_bib0030","first-page":"62","article-title":"Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment","volume":"15","author":"Henon","year":"2001","journal-title":"J Biol Regul Homeost Agents"},{"issue":"4","key":"10.1016\/j.jcyt.2021.04.001_bib0031","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1365-2141.2001.03027.x","article-title":"Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve","volume":"114","author":"Pratt","year":"2001","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.jcyt.2021.04.001_bib0032","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0301-472X(01)00726-3","article-title":"CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation","volume":"29","author":"Lanza","year":"2001","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.04.001_bib0033","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2141.2002.03373.x","article-title":"CD34+\/CD90+ cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation","volume":"117","author":"Sumikuma","year":"2002","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.jcyt.2021.04.001_bib0034","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bmt.1703575","article-title":"Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation","volume":"29","author":"Allan","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2021.04.001_bib0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1423-0410.2007.01009.x","article-title":"Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation","volume":"94","author":"Lee","year":"2008","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.jcyt.2021.04.001_bib0036","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.transci.2014.02.021","article-title":"Pre infusion, post thaw CD34+ peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantation","volume":"50","author":"D'Rozario","year":"2014","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.jcyt.2021.04.001_bib0037","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/14653240410004925","article-title":"Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells\/kg","volume":"6","author":"Abrahamsen","year":"2004","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.jcyt.2021.04.001_bib0038","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bmt.1705009","article-title":"Recovery of viable CD34+ cells from cryopreserved hemopoietic progenitor cell products","volume":"36","author":"Sartor","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jcyt.2021.04.001_bib0039","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1423-0410.2007.001028.x","article-title":"Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity","volume":"94","author":"Reich-Slotky","year":"2008","journal-title":"Vox Sang"},{"issue":"4","key":"10.1016\/j.jcyt.2021.04.001_bib0040","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/trf.12428","article-title":"Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation","volume":"54","author":"Fisher","year":"2014","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.jcyt.2021.04.001_bib0041","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0301-472X(01)00750-0","article-title":"Dissociation between stem cell phenotype and NOD\/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion","volume":"29","author":"Danet","year":"2001","journal-title":"Exp Hematol"},{"issue":"10","key":"10.1016\/j.jcyt.2021.04.001_bib0042","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/sctm.17-0048","article-title":"Brief Report: A Differential Transcriptomic Profile of Ex Vivo Expanded Adult Human Hematopoietic Stem Cells Empowers Them for Engraftment Better than Their Surface Phenotype","volume":"6","author":"Psatha","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2021.04.001_bib0043","doi-asserted-by":"crossref","first-page":"40","DOI":"10.21037\/sci.2017.05.03","article-title":"Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications","volume":"4","author":"Servais","year":"2017","journal-title":"Stem Cell Investig"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921002267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921002267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:44:46Z","timestamp":1761443086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324921002267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1465324921002267"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.04.001","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a clinical-grade, cryopreserved, ex vivo-expanded stem cell product from cryopreserved primary umbilical cord blood demonstrates multilineage hematopoietic engraftment in mouse xenografts","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}